From Bench to Bedside: Targeted Therapy, Denosumab, and 21st Century Orthopaedics: Targets Abound, But Where Are The Therapies?
Potter, Benjamin K
From Bench to Bedside: Targeted Therapy, Denosumab, and 21st Century Orthopaedics: Targets Abound, But Where Are The Therapies? [electronic resource] - Clinical orthopaedics and related research Apr 2016 - 892-4 p. digital
Publication Type: Journal Article
1528-1132
10.1007/s11999-016-4734-2 doi
Animals
Antineoplastic Agents--adverse effects
Bone Density Conservation Agents--adverse effects
Cost-Benefit Analysis
Denosumab--adverse effects
Diffusion of Innovation
Drug Costs
Drug Discovery--economics
Humans
Molecular Targeted Therapy--economics
Research Support as Topic
Translational Research, Biomedical--economics
From Bench to Bedside: Targeted Therapy, Denosumab, and 21st Century Orthopaedics: Targets Abound, But Where Are The Therapies? [electronic resource] - Clinical orthopaedics and related research Apr 2016 - 892-4 p. digital
Publication Type: Journal Article
1528-1132
10.1007/s11999-016-4734-2 doi
Animals
Antineoplastic Agents--adverse effects
Bone Density Conservation Agents--adverse effects
Cost-Benefit Analysis
Denosumab--adverse effects
Diffusion of Innovation
Drug Costs
Drug Discovery--economics
Humans
Molecular Targeted Therapy--economics
Research Support as Topic
Translational Research, Biomedical--economics